Published in Blood Weekly, April 13th, 1998
Polycythemia vera (PV) is marked by a great increase in the number of red cells in the blood, resulting in headaches and potentially fatal blood clots. It usually is treated by a modern form of bloodletting, although more severe cases may require chemotherapy.
A unique molecular defect in the unusual blood disorder, first identified and described at Johns Hopkins by the late Sir William Osler almost a century ago, has been discovered by a team of his professional descendants. The molecular defect that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.